Future trends in the treatment of brain tumours
- 31 December 2001
- journal article
- editorial
- Published by Elsevier BV in European Journal of Cancer
- Vol. 37 (18), 2297-2301
- https://doi.org/10.1016/s0959-8049(01)00301-x
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: A phase II studyAnnals of Oncology, 2001
- High-Dose Chemotherapy with Bone Marrow Rescue for High-Grade Gliomas in AdultsCancer Investigation, 2001
- Randomized Trial of Procarbazine, Lomustine, and Vincristine in the Adjuvant Treatment of High-Grade Astrocytoma: A Medical Research Council TrialJournal of Clinical Oncology, 2001
- Effect of disease burden on health-related quality of life in patients with malignant gliomasNeuro-Oncology, 2000
- A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapseBritish Journal of Cancer, 2000
- Phase I Trial to Determine the Safety, Pharmacodynamics, and Pharmacokinetics of RSR13, a Novel Radioenhancer, in Newly Diagnosed Glioblastoma MultiformeJournal of Clinical Oncology, 1999
- Current Approaches to Radiation Therapy for Malignant GliomasFrontiers of radiation therapy and oncology, 1999
- Malignant glioma: Who benefits from adjuvant chemotherapy?Annals of Neurology, 1998
- Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic OligodendrogliomasJNCI Journal of the National Cancer Institute, 1998
- Randomized study of brachytherapy in the initial management of patients with malignant astrocytomaInternational Journal of Radiation Oncology*Biology*Physics, 1998